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Background: Primary-care veterinary clinical records can offer data to determine generalizable
epidemiological data on seizures occurrence in the dog population.
Objectives: To identify and examine epidemiologic characteristics of seizure occurrence in dogs
under primary veterinary care in the UK participating in the VetCompass™ Programme.
Animals: 455,553 dogs in VetCompass™’.
Methods: A cross-sectional analysis estimated the 1-year period prevalence and risk factors for
dogs with seizures during 2013.
Results: The overall 1-year period prevalence for dogs having at least one seizure during 2013
was 0.82% (95% CI 0.79-0.84). Multivariable modelling identified breeds with elevated odd
ratios [OR] compared with the Labrador Retriever (e.g. Pug OR: 3.41 95% CI 2.71-4.28, P <
0.001). Males had higher risk for seizures (Male/Entire OR: 1.47 95% CI 1.30–1.66; Male/Neu-
tered OR: 1.34 95% CI 1.19–1.51) compared to entire females. Age (3.00 - ≤ 6.00 OR: 2.13 95%
CI 1.90-2.39, P < 0.001, compared to animals aged 0.50–≤ 3.00 years), and bodyweight (≥
40.00kg, OR: 1.24 95% CI 1.08–1.41, P = 0.002, compared to animals weighing < 10.0 kg) were
identified as risk factors for seizures.
Conclusion and clinical Importance: Seizures are a relatively common clinical finding in dogs.
The results for breed, age, sex and bodyweight as risk factors can assist veterinarians in refining
differential diagnosis lists for dogs reported with behaviors that may have been seizures. In addi-
tion, the prevalence values reported here can support pharmacovigilance with baseline data
from the overall population.
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1 | INTRODUCTION
Seizures in dogs are sudden, short lasting and transient events that
are characterized by motor, autonomic or behavioral features.1 They
are considered common events in dogs.2 Causes including genetic and
insult-triggered brain diseases, peripheral diseases, electrolyte
imbalances, intoxications and idiopathic.3 Seizure activity can have
substantial impact on quality of life3–5 as well as causing emotional
distress for owners.6,7 To date, most studies have focused on the sub-
set of cases that are classified as epileptic.8,9
Seizures are either epileptic or reactive according to the classifica-
tion of the IVETF. Epileptic seizures are manifestations of excessive
synchronous neuronal activity in the brain that is usually self-limiting
and that are promoted by a predisposition of the brain for ictogen-
esis.1,10 Epilepsy is usually defined as requiring at least two unpro-
voked epileptic seizures more than 24 hours apart11 and reactive
seizures (also called provoked seizures) are considered as natural
Abbreviations: CI, confidence interval; EPR, electronic patient record; IQR,
interquartile range; OR, odds ratio; PMS, practice management system; ROC,
receiver operating characteristic; RVC, Royal Veterinary College; UK, United
Kingdom; CNS, central nervous system; DYAR, dog years at risk; IVETF, Interna-
tional Veterinary Epilepsy Task Force
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responses from the normal brain to some transient disturbance in
function (e.g. metabolic or toxic) which is reversible when the cause or
disturbance is rectified.1,3 Analysis of a large pet insurance database
reported an epilepsy incidence of 18 per 10,000 dog years at risk
(DYAR) in Sweden for either idiopathic epilepsy or epileptic convul-
sions.8 A study using primary-care veterinary clinical data reported a
prevalence of 0.62% for epilepsy in dogs in the UK.9 A cross sectional
study compared period prevalence of epileptic seizures in a 2.5-year
observation period between first opinion practices (0.43%) and a
referral clinic in southern Germany (1.78%).12 Among the referral sub-
set of dogs seen at a veterinary teaching hospital in Germany, 2.6%
had a history of seizures reported.13 Epidemiological studies using first
opinion databases that explore seizures in general rather than relying
on semi-arbitrary classification into various subsets might offer novel
and more clinically pertinent insights into this disease in dogs. There
are breed predispositions to various forms of epilepsy, but predisposi-
tion studies often fail to describe the prevalence of seizures either in
dogs overall and in individual breeds.
This study aimed to identify and explore seizure occurrence in the
general dog population under primary veterinary care in the UK. The
specific objectives were to estimate the 1-year period prevalence for
dogs that showed seizures and to also identify demographic risk fac-
tors associated with dogs that showed seizures, with breed as a risk
factor of special interest. These results could be especially valuable
for practitioners, insurance companies, pharmaceutical and nutrition
manufacturers and pharmacovigilance agencies by providing a repre-
sentative evidence-base that can be generalized to the wider dog pop-
ulation and fill the evidential data gap on seizure occurrence.
2 | MATERIALS AND METHODS
This study was based on data collected within the VetCompass™ Ani-
mal Surveillance System 14 at the Royal Veterinary College (RVC).
VetCompass™ collates electronic patient record (EPR) data from hun-
dreds of UK primary-care practices for epidemiological research.
Demographic information collected included species, breed, date of
birth, sex and neuter status, while clinical information includes free
text notes, treatment data as well as summarized diagnosis terms from
the VeNom Codes standardized lists.15 Clinical data from participating
practices are extracted from practice management systems (PMSs)
using automated queries, uploaded securely to the RVC server and
reformatted for entry into the VetCompass™ online database
system.16
A cross-sectional analysis using cohort clinical data of dogs
attending VetCompass™ practices was used to estimate the 1-year
period prevalence and risk factors for dogs with at least one seizure
during 2013.17 The denominator population for the current study
comprised all dogs that had at least one EPR (clinical note, bodyweight
or treatment) recorded in VetCompass™ during 2013 or dogs that
had ‘at least one EPR before and one EPR after 2013’. These dogs
were defined as being under veterinary care during 2013.
Sample size calculations estimated that a study with 149,698
dogs would be required to represent a disorder with 1% expected
prevalence to a precision of 0.05% at a 95% confidence level from an
estimated UK national population of 9.4 million dogs.18,19 Ethical
approval was granted by the RVC Ethics and Welfare Committee (ref-
erence number 2015 1369).
A two-step letter-string search process was used to identify sei-
zure cases in the VetCompass™ dog population. In step one, all EPRs
were initially screened for candidate seizure cases using a range of
letter-string search terms including seiz*, siez*, convul*, tonic*,
clonic*, myoclo*, “had fit”, “had a fit”, epil*, diaz*, clonaz*, midazol*,
phenobarb*, gabapen*, levetira*, bromide, pregaba*, zonis*, imepit*,
pexi*, keppr*, hypnov*, epiph*, phenolep*, librom*, lyric*, alpraz* and
zoneg*. In step two, the EPRs of all candidate cases which had been
identified as possible seizure cases were manually read and evaluated
for inclusion as a seizure case according to the study case definition.
A seizure case was defined as any dog with at least one seizure event
occurring during 2013 recorded in the EPR. All dogs with reported sei-
zure activity in 2013 were grouped as seizure cases and all remaining
dogs were grouped as non-cases.
A “Purebred “variable classified all dogs of a recognizable breed
as” purebred”, all dogs recorded with a designer breed name as
“designer” 20 and all remaining dogs as “crossbred” . A “Breeds” vari-
able included the breed name of any individual purebred or designer
breed types with 15 or more seizure cases during 2013 while all
remaining purebred and designer types were grouped as “Other pure-
breds and designers breed types” and a general category of crossbred
dogs was also included. A “Kennel Club Breed Group” variable defined
all KC recognized breeds according to their relevant UK KC breed
groups (Gundog, Terrier, Utility, Hound, Working, Toy and Pastoral)
and included all remaining dogs as “Breed not-Kennel Club recog-
nized”. The age for all dogs described the age at 31st December 2013.
An age variable “Age” contained 7 age categories in years (0.00 - ≤
0.50, 0.50 - ≤ 3.00, 3.00 - ≤ 6.00, 6.00 - ≤ 9.00, 9.00 - ≤ 12.00, ≥
12.00, unrecorded) according to the IVETF guidelines.21 The “Neuter
status” variable recorded the neutering status recorded at the final
EPR. Sex and neuter status were also combined into a single variable
(Sex-neuter) that reported the results across seven permutational cat-
egories. The variable “Adult (> 18 months) bodyweight” described the
maximum bodyweight recorded during the study period for dogs older
than 18 months and categorized adult bodyweight into 6 groups (<
10.00 kg, 10.00 - ≤ 20.00 kg, 20.00 - ≤ 30.00 kg, 30.00 - ≤ 40.00 kg, ≥
40.00 kg, unrecorded). A “Bodyweight relative to breed and sex mean”
variable characterized the adult bodyweight of individual dogs as
either below or equal/above the mean adult bodyweight for their
breed and sex within the overall study population. This variable
allowed the effect of adult bodyweight to be assessed within each
breed/sex combination.
After data checking and cleaning in Excel (Microsoft Office Excel
2013, Microsoft Corp.), statistical analyses were conducted with IBM
SPSS Statistics 24®. The 1-year period prevalence with 95% confi-
dence intervals (CI) described the probability for each dog of having at
least one seizure at any time during the 1-year 2013 study period.
The CI estimates were derived from standard errors, based on approx-
imation to the normal distribution.22 Descriptive statistics character-
ized the count and proportions of cases and non-case dogs for each
of the study variables. Binary logistic regression modelling was used
to evaluate univariable associations between risk factors and being a
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seizure case. Because breed was a factor of primary interest for the
study, purebred status and Kennel Club Breed group (highly correlated
with breed), and adult (>18months) bodyweight (a defining character-
istic of individual breeds) were excluded from the initial breed multi-
variable modelling. Instead, each of these variables individually
replaced the breed variable in the main final breed model in order to
evaluate their effects after taking account of the other variables and
these results were reported. Risk factors with liberal associations in
univariable modelling (P < 0.2) were taken forward for multivariable
logistic regression modelling evaluation. Model development used
automated backwards stepwise elimination. The area under the ROC
curve was used to assess the quality of the model fit. Statistical signifi-
cance was set at P < 0.05.
3 | RESULTS
The study population comprised 455,553 dogs attending primary care
practices in the UK participating in VetCompass™. Initial screening
identified 10,584 candidate cases. After manual review, 3,731
(35.25%) dogs met the seizure inclusion criteria giving an overall
1-year period prevalence of 0.82% (95% CI 0.79 - 0.84) for dogs hav-
ing at least one seizure. Individual breeds with the highest seizure
prevalence included Pug (1.88% of the breed affected, 95% CI 1.52 -
2.24), Boxer (1.77%, 95% CI 1.44 - 2.09), Basset Hound (1.74%, 95%
CI 1.02 - 2.46), Border Terrier (1.67%, 95% CI 1.33 - 2.01) and Border
Collie (1.45%, 95% CI 1.24 - 1.66) (Table 1).
The most common breeds among the non-case dogs were the
Labrador Retriever 32,998 (7.3%), Staffordshire Bull Terrier 32,407
(7.2%), Jack Russell Terrier 27,473 (6.1%), Cocker Spaniel 15,765
(3.5%), Yorkshire Terrier 15,248 (3.4%) as well as 100,249 (22.2%)
crossbreds and 13,768 (3.0%) designers (Table 2). Of the non-case
dogs, 337,805 (74.8%) were purebred and 232,080 (51.4%) were
male. Of the males, 91,692 (20.3%) were entire and 102,968 (22.8%)
were neutered (neuter status was not available for the remainer). The
median adult bodyweight for non-cases was 16.60 kg (interquartile
range [IQR]: 9.00 - 28.00, range: 0.30 - 112.00) and the median age
was 4.09 years (IQR: 1.70 - 7.58, range: 0.00 - 24.68) (Fig 1).
Of the seizure cases, 2,962 (79.4%) were purebred, 2,131 (57.1%)
were male. Of the males 731 (19.6%) were entire and 934 (25.0%)
were neutered (neuter status was not available for the remainer).
Across both sexes combined, 1,767 (47.3%) dogs were neutered. Dogs
with seizures had a median adult bodyweight of 18.20 kg (IQR: 9.30 -
30.45, range: 0.80 - 86.90) and median age of 7.27 years (IQR: 4.23 -
11.07, range: 0.11 - 23.23) (Fig 1). The most common breeds among
the seizure cases were Labrador Retriever (323/3,731 cases, 8.7% of
all cases), Staffordshire Bull Terrier (228/3,731, 6.1%), Jack Russell
Terrier (218/3,731, 5.8%), Border Collie (178/3,731, 4.8%) and York-
shire Terrier (178/3,731, 4.8%) as well as crossbreds (681/3,731,
18.3%) and designer dogs (78/3,731, 2.1%), (Table 2).
Data completeness varied between the variables assessed: breed
100.0%, age 98.6%, sex 99.5%, bodyweight (> 18 months) 72.8% and
neuter 84.1%. Univariable logistic regression modelling identified five
variables that were liberally associated with seizures and were further
evaluated in the main multivariable logistic regression modelling:
breed, age, bodyweight relative to breed and sex mean, neuter status,
sex and sex-neuter (Table 2). The final breed multivariable logistic
regression model showed good discrimination (area under the ROC
curve: 0.714). After accounting for the effects of the other variables
evaluated, 11 breed types had significantly increased odds of seizures
compared with Labrador Retriever dogs. The breeds with the highest
odd ratios (OR) included the Pug (OR: 3.41 95% CI 2.71 - 4.28, P <
0.001), Basset Hound (OR: 2.13 95% CI 1.38 - 3.30, P < 0.001), Dogue
de Bordeaux (OR: 2.10 95% CI 1.37 - 3.22, P < 0.001), Boxer (OR:
1.95 95% CI 1.57 - 2.42, P < 0.001) and Beagle (OR: 1.91 95% CI
1.40 - 2.59, P < 0.001). Breeds with a significant lower OR of seizures
in comparison to Labrador Retrievers were the Shih-tzu (OR: 0.53,
95% CI 0.40 - 0.70, P < 0.001), West Highland White Terrier (OR:
0.52, 95% CI 0.40 - 0.67, P < 0.001), English Springer Spaniel (OR:
0.50, 95% CI 0.34 - 0.74, P < 0.001) and Cocker Spaniel (OR: 0.44,
95% CI 0.34 - 0.58, P < 0.001). Crossbred dogs presented as well sig-
nificantly reduced odds for seizures in comparison to Labrador
Retriever (OR: 0.75 95% CI 0.66 - 0.86 P < 0.001). Compared with
dogs aged between 0.50 - ≤ 3.00 years, dogs aged 3.00 - ≤ 6.00 years
had 2.13 times the odds (95% CI 1.90 - 2.39, P < 0.001) for seizures.
Dogs younger than 0.50 years had reduced odds (OR: 0.30 95% CI
0.20 - 0.45, P < 0.001) for seizures. The results showed a general
trend towards increasing odds with increasing age. Males, regardless
of neuter status had higher odds of seizures compared with entire
females (Table 3).
As described in the methods, three variables (Purebred status,
Kennel Club Breed groups, Adult (> 18months) bodyweight individu-
ally replaced the breed variable in the final multivariable breed model.
Purebred dogs had 1.28 times the odds (95% CI 1.18 - 1.39, P <
0.001) compared with crossbred dogs. Compared with “Breeds not
Kennel Club recognized”, the “Toy” Kennel Club Breed group showed
1.68 times the odds (95% CI 1.52 - 1.86 P < 0.001), the “Working”
group had 1.49 the odds (95% CI 1.29 - 1.73, P < 0.001) and the “Pas-
toral” group had 1.42 the odds (95% CI 1.26 - 1.61, P < 0.001). Dogs
with an adult (> 18months) bodyweight ≥ 40.00 kg had 1.24 times the
odds (95% CI 1.08 - 1.41, P = 0.002) compared with dogs < 10.00 kg
(Table 4).
4 | DISCUSSION
This study explored the occurrence of seizures in a UK dog population
under primary veterinary care. It benefitted from a large sample size
of over 450,000 dogs. The study reports an overall 1-year period
prevalence of 0.82% and identified the Pug, Boxer, Basset Hound,
Border Terrier and Border Collie as the breeds with the highest sei-
zure prevalence. Increasing age, being male, being purebred and
weighing over 40kg were highlighted as significant risk factors. These
results can assist veterinary clinicians, researchers, breeders and phar-
macovigilance agencies by providing a reliable evidence resource. This
study also highlights the value of developing similar large-scale sys-
tems for collection and analysis of veterinary clinical data outside of
the UK in order to generate evidence that will be more generalizable
to their national animal populations.
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The VetCompass™ database was selected as a useful data source
for the current study that aimed to provide a prevalence estimate for
dogs with seizures with high levels of validity, generalizability and pre-
cision for the general population of dogs in the UK. Primary-care vet-
erinary clinical data might lack diagnostic precision for complicated
disorders due to financial constraints on clinical work-up, but are
much less affected by the selection biases and therefore the results
are thought to have greater validity than referral studies that prefer-
entially select for dogs that are by definition sick and generally
affected with more complicated disease and more severe presenta-
tions and owned by more motivated owners.23 Primary-care data col-
lected and merged from many hundreds of clinics now offers study
sample sizes of sufficiently large size to allow much greater numerical
precision in results than has previously been possible.23 It is estimated
that 70% of UK dogs are registered with a veterinary practice and
therefore results of studies using primary-care data offer good pros-
pects of generalization to the wider dog population and clinical rele-
vance of the emergent results to veterinarians.19,24








Pug 101 5376 4.95 (2.76-6.99) 1.88 1.52-2.24
Boxer 111 6288 9.52 (6.95-11.04) 1.77 1.44-2.09
Basset Hound 22 1263 6.22 (3.19-9.36) 1.74 1.02-2.46
Border Terrier 91 5449 7.06 (4.85-11.35) 1.67 1.33-2.01
Border Collie 178 12268 6.43 (4.18-12.18) 1.45 1.24-1.66
Beagle 48 3508 5.71 (5.46-7.35) 1.37 0.98-1.75
King Charles Spaniel 21 1666 5.18 (3.03-11.33) 1.26 0.72-1.80
Dogue de Bordeaux 23 1858 3.76 (2.05-5.91) 1.24 0.73-1.74
British Bulldog 39 3374 2.54 (1.58-4.46) 1.16 0.80-1.52
Weimaraner 18 1568 8.30 (6.90-10.73) 1.15 0.62-1.68
Yorkshire Terrier 178 15426 8.23 (5.33-12.44) 1.15 0.99-1.32
Cavalier King Charles Spaniel 112 10143 6.95 (4.91-9.20) 1.10 0.90-1.31
Patterdale Terrier 26 2433 5.58 (3.35-8.31) 1.07 0.66-1.48
Pomeranian 22 2147 4.95 (1.81-6.97) 1.02 0.60-1.45
Labrador Retriever 323 33321 7.21 (4.48-9.91) 0.97 0.87-1.06
Toy Poodle 18 1881 7.60 (4.06-12.83) 0.69 0.52-1.40
Golden Retriever 54 5670 8.33 (5.02-12.40) 0.95 0.70-1.21
German Shepherd Dog 116 12520 8.59 (5.35-10.98) 0.93 0.76-1.09
Chihuahua 101 11782 4.04 (1.85-6.67) 0.86 0.69-1.02
Akita 17 2105 7.36 (3.45-13.32) 0.81 0.42-1.19
Miniature Schnauzer 31 3857 6.30 (3.04-10.66) 0.80 0.52-1.09
French Bulldog 19 2397 2.18 (1.56-6.00) 0.79 0.44-1.15
Jack Russell Terrier 218 27691 8.59 (5.39-12.83) 0.79 0.68-0.89
Labradoodle 23 3132 4.47 (3.73-6.80) 0.73 0.44-1.03
Miniature Dachshhund 20 2792 5.64 (4.07-8.14) 0.72 0.40-1.03
Staffordshire Bull Terrier 228 32635 7.97 (4.40-10.97) 0.70 0.61-0.79
Crossbred 681 98931 8.23 (4.57-12.71) 0.96 0.64-0.74
Lurcher 22 3222 5.78 (3.17-11.32) 0.68 0.40-0.97
Husky 28 4162 4.55 (1.66-5.91) 0.67 0.42-0.92
West Highland White Terrier 73 12017 10.94 (5.78-13.83) 0.61 0.47-0.75
Springer Spaniel 35 5800 10.04 (5.71-12.78) 0.60 0.40-0.80
Lhasa Apso 38 6840 8.80 (4.75-12.91) 0.56 0.38-0.73
Bichon 36 6607 8.67 (3.84-12.63) 0.54 0.37-0.72
English Springer Spaniel 29 5384 7.86 (3.92-11.71) 0.54 0.34-0.73
Unrecorded 10 2009 9.18 (4.58-14.76) 0.50 0.19-0.81
Rottweiler 24 5321 6.34 (4.91-10.69) 0.45 0.27-0.63
Designer 33 7492 3.11 (1.89-4.98) 0.44 0.29-0.59
Cocker Spaniel 62 15827 8.08 (4.72-11.15) 0.39 0.29-0.49
Shih-tzu 57 15038 8.24 (4.75-13.56) 0.38 0.28-0.48
Other purebreds and designers breed types 445 54353 7.32 (4.19-10.90) 0.82 0.74-0.89
Overall total 3731 455553 7.27 (4.23-11.07) 0.82 0.79-0.84
One-year period prevalence of seizures in commonly affected dog breeds under primary veterinary care in the UK; aCI confidence interval.
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Purebred Crossbred 681 (18.3) 98250 (21.7) Base < 0.001
Designer 78 (2.1) 13768 (3.0) 0.82 0.65-1.03 0.092
Purebred 2962 (79.4) 337805 (74.8) 1.27 1.16-1.38 < 0.001
Unrecorded 10 (0.3) 1999 (0.4) 0.72 0.39-1.35 0.31
Breeds Labrador Retriever 323 (8.7) 32998 (7.3) Base < 0.001 < 0.001
Pug 101 (2.7) 5275 (1.2) 1.96 1.56-2.45 < 0.001
Boxer 111 (3.0) 6177 (1.4) 1.84 1.48-2.28 < 0.001
Basset Hound 22 (0.6) 1241 (0.3) 1.81 1.17-2.80 0.008
Border Terrier 91 (2.4) 5358 (1.2) 1.74 1.37-2.19 < 0.001
Border Collie 178 (4.8) 12090 (2.7) 1.50 1.25-1.81 < 0.001
Beagle 48 (1.3) 3460 (0.8) 1.42 1.04-1.92 0.025
King Charles Spaniel 21 (0.6) 1645 (0.4) 1.30 0.84-2.03 0.24
Dogue de Bordeaux 23 (0.6) 1835 (0.4) 1.28 0.84-1.96 0.26
British Bulldog 39 (1.0) 3335 (0.7) 1.19 0.86-1.67 0.30
Yorkshire Terrier 178 (4.8) 15248 (3.4) 1.19 0.99-1.43 0.061
Weimaraner 18 (0.5) 1550 (0.3) 1.19 0.74-1.91 0.48
Cavalier King Charles Spaniel 112 (3.0) 10031 (2.2) 1.14 0.92-1.42 0.23
Patterdale Terrier 26 (0.7) 2407 (0.5) 1.10 0.74-1.65 0.63
Pomeranian 22 (0.6) 2125 (0.5) 1.06 0.69-1.63 0.80
Toy Poodle 18 (0.5) 1863 (0.4) 0.99 0.61-1.59 0.96
Golden Retriever 54 (1.4) 5616 (1.2) 0.98 0.74-1.31 0.90
German Shepherd Dog 116 (3.1) 12404 (2.7) 0.96 0.77-1.18 0.68
Chihuahua 101 (2.7) 11681 (2.6) 0.88 0.71-1.11 0.28
Akita 17 (0.5) 2088 (0.5) 0.83 0.51-1.36 0.46
Miniature Schnauzer 31 (0.8) 3826 (0.8) 0.83 0.57-1.20 0.32
French Bulldog 19 (0.5) 2378 (0.5) 0.82 0.51-1.30 0.39
Jack Russell Terrier 218 (5.8) 27473 (6.1) 0.81 0.68-0.96 0.017
Labradoodle (Designer) 23 (0.6) 3109 (0.7) 0.76 0.49-1.16 0.20
Miniature Dachshund 20 (0.5) 2772 (0.6) 0.74 0.47-1.16 0.19
Staffordshire Bull Terrier 228 (6.1) 32407 (7.2) 0.72 0.61-0.85 < 0.001
Crossbred 681 (18.3) 98250 (21.7) 0.71 0.62-0.81 < 0.001
Lurcher (Designer) 22 (0.6) 3200 (0.7) 0.70 0.46-1.08 0.11
Husky 28 (0.8) 4134 (0.9) 0.69 0.47-1.02 0.063
West Highland White Terrier 73 (2.0) 11944 (2.6) 0.62 0.48-0.81 < 0.001
Springer Spaniel 35 (0.9) 5765 (1.3) 0.62 0.44-0.88 0.007
Lhasa Apso 38 (1.0) 6802 (1.5) 0.57 0.41-0.80 0.001
Bichon 36 (1.0) 6571 (1.5) 0.56 0.40-0.79 0.001
English Springer Spaniel 29 (0.8) 5355 (1.2) 0.55 0.38-0.81 0.002
Rottweiler 24 (0.6) 5297 (1.2) 0.46 0.31-0.70 < 0.001
Designer 33 (0.9) 7459 (1.6) 0.45 0.32-0.65 < 0.001
Cocker Spaniel 62 (1.7) 15765 (3.5) 0.40 0.31-0.53 < 0.001
Shih-tzu 57 (1.5) 14981 (3.3) 0.39 0.29-0.52 < 0.001
Unrecorded 10 (0.3) 1999 (0.4) 0.51 0.27-0.96 0.037
Other purebreds and
designers breed types





1074 (28.8) 151937 (33.6) Base < 0.001
Gundog 589 (15.8) 72359 (16.0) 1.15 1.04-1.27 0.006
Hound 139 (3.7) 15832 (3.5) 1.23 1.03-1.47 0.021
Pastoral 331 (8.9) 29374 (6.5) 1.59 1.41-1.80 < 0.001
Terrier 462 (12.4) 58643 (13.0) 1.12 0.99-1.24 0.052
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The current study reported a 1-year prevalence of 0.82% for dogs
affected by at least one seizure. To our knowledge, no previous studies
have reported on the prevalence of seizures in the general dog popula-
tion that can be used for direct comparison to this result. An earlier
VetCompass™ study using primary-care data reported a prevalence of
0.62% for epilepsy of unknown origin in the UK.9 This earlier study cov-
ered a longer period from January 2010 to April 2011 and focused spe-
cifically on the subset of dogs with “epilepsy of unknown origin”,
excluding any dogs which had a clinically identified underlying disease
causing epilepsy, whereas the current study included all dogs with sei-
zures from any etiology during a 1-year period. Thus, the previous
reported prevalence is lower than the value reported in the current
study as would be expected. Analysis of claim data from a large insur-
ance database in Sweden reported a 0.75% prevalence of insured dogs
with a recorded claim for epilepsy.8 However, this prevalence among
insured dogs might be higher than in the wider dog population under
veterinary care because certain breed types perceived to have higher
health risks may be preferentially insured.25 Furthermore, the study
dogs contributed an average of 4.2 years to the insurance study com-
pared with the 1-year period included in the current study. Further
studies have also reported on referral populations.13,26,27 One of these
studies reported a total seizure prevalence of 2.6% in a hospital popula-
tion in Germany comprising 394 seizure case dogs admitted between
January 2002 and March 2008.13 This prevalence may exceed the
0.82% reported in the current UK primary-care study because primary-
care caseloads include 24.2% of dogs that have no diseases recorded
and many of the remaining have minor ailments.23,28 However, further
factors that could partially account for the differences need to be con-
sidered and may include geographic and temporal differences between













Toy 617 (16.5) 56704 (12.6) 1.54 1.39-1.70 < 0.001
Utility 307 (8.2) 44855 (9.9) 0.97 0.85-1.10 0.62
Working 212 (5.7) 22118 (4.9) 1.36 1.17-1.57 < 0.001
Adult (>18months)
bodyweight (kg)
< 10.00 878 (23.5) 98359 (21.8) Base < 0.001 < 0.001
10.00 - ≤ 20.00 830 (22.3) 91219 (20.2) 1.02 0.93-1.12 0.69
20.00 - ≤ 30.00 641 (17.2) 67845 (15.0) 1.06 0.95-1.17 0.29
30.00 - ≤ 40.00 526 (14.1) 46004 (10.2) 1.28 1.15-1.43 < 0.001
≥ 40.00 313 (8.4) 24860 (5.5) 1.41 1.24-1.61 < 0.001
Unrecorded 543 (14.6) 123535 (27.2) 0.49 0.44-0.55 < 0.001
Bodyweight relative
to breed and sex mean
Lower 1636 (43.9) 182105 (40.3) Base < 0.001
Equal/Higher 1550 (41.5) 145848 (32.4) 1.18 1.10-1.27 < 0.001
Unrecorded 545 (14.6) 123869 (27.3) 0.49 0.44-0.54 < 0.001
Age (years) 0.00 - ≤ 0.50 25 (0.7) 25508 (5.6) 0.28 0.19-0.42 < 0.001 < 0.001
0.50 - ≤ 3.00 522 (14.0) 148813 (32.9) Base
3.00 - ≤ 6.00 923 (24.7) 114584 (25.4) 2.30 2.06-2.56 < 0.001
6.00 - ≤ 9.00 832 (22.3) 76360 (16.9) 3.10 2.78-3.46 < 0.001
9.00 - ≤ 12.00 636 (17.1) 47228 (10.5) 3.84 3.42-4.31 < 0.001
≥ 12.00 767 (20.6) 33180 (7.3) 6.59 5.89-7.37 < 0.001
Unrecorded 26 (0.7) 6149 (1.4) 1.21 0.81-1.79 0.35
Sex Female 1592 (42.7) 217440 (48.1) Base < 0.001
Male 2131 (57.1) 232080 (51.4) 1.25 1.17-1.34 < 0.001
Not recorded 8 (0.2) 2302 (0.5) 0.48 0.24-0.95 0.036
Neuter status Entire 1150 (30.8) 177066 (39.1) Base < 0.001
Neutered 1767 (47.3) 203252 (45.0) 1.34 1.24-1.44 < 0.001
Unrecorded 814 (21.8) 71504 (15.9) 1.75 1.60-1.92 < 0.001
Sex-neuter Female/Entire 412 (11.0) 83498 (18.5) Base < 0.001
Female/Neutered 832 (22.3) 100164 (22.2) 1.68 1.50-1.90 < 0.001
Female/Unrecorded 348 (9.3) 33778 (7.5) 2.09 1.81-2.41 < 0.001
Male/Entire 731 (19.6) 91692 (20.3) 1.62 1.43-1.82 < 0.001
Male/Neutered 934 (25.0) 102968 (22.8) 1.84 1.64-2.06 < 0.001
Male/Unrecorded 466 (12.5) 37420 (8.3) 2.52 2.21-2.88 < 0.001
Unrecorded/Unrecorded 8 (0.2) 2302(0.5) 0.70 0.35-1.42 0.33
Descriptive and univariable regression results for risk factors associated with seizure events in dogs under veterinary primary-care in the UK. Percentages
shown in brackets aCI confidence interval.
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The 1-year period prevalence of 0.82% identifies seizures as a rel-
atively frequent clinical presentation in the UK dog population under
primary veterinary care. Seizures are a clinical manifestation that can
result from a wide variety of causes, but are not limited to, genetic
predisposition, primary brain disease, intoxication, cardiovascular dis-
ease, electrolyte disturbance and endocrine and metabolic disorders.23
The proportional contribution of reactive seizures to the total seizure
case burden has been variously estimated at between 13.6% and 32%
respectively.13,26,27 The differences between the study outcome
might result from variation between study design (e.g. prospective
versus retrospective analyses), countries, diagnostic procedures and
animal population selection (e.g. primary-care versus referral case-
loads). The results of the current study underline the relevance of
undergraduate training and continuing education about the multiple
causes of seizure events, the optimal diagnostic procedures, and the
management options for seizure events in dogs. These period preva-
lence data should also be considered as a useful background presence
of seizures when considering suspected adverse events reported to
pharmacovigilance monitoring systems.29,30
Risk factors results can provide valuable information to improve
veterinary diagnosis of disease and hence to improve animal welfare
monitoring.31 The current study placed special focus on exploring breed
as a risk factor for seizure occurrence because of prior evidence of
genetic associations with epilepsy in dogs.26 As might have been
expected, seizures proved to be more frequent in purebreds compared
to crossbred and designer dogs although the purebred predisposition
could be heavily influenced by the subgroup of dogs with idiopathic
epilepsy. In a recent longitudinal study at Copenhagen University Hos-
pital, dogs with idiopathic epilepsy exhibited a breed distribution of
83.6% purebred and 16.4% crossbred.26 However, hereditary factors
might also contribute to structural epilepsy as well as non-epileptic sei-
zures cases as the genetic background might, for instance, predispose
to epilepsy development after a brain injury or might predispose to a
peripheral disease associated with non-epileptic seizures.
Hybrid vigor (also known as heterosis or crossbred vigor)
describes a phenomenon whereby the average performance of first-
generation crosses for specified traits outperforms the average perfor-
mance of their parental breeds 32 and has been proposed to enhance
the health of crossbred compared with purebred animals for over
150 years.33 Substantial evidence exists for these effects in produc-
tion species of plants 34 and animals.35–37 However, pet dogs are gen-
erally not kept for production traits and the strength of evidence to
support the true impact of hybrid vigor in dogs has recently been
questioned.38 The findings in the current study that purebred dogs
had 1.28 times higher odds of being seizure cases compared with
crossbreds might add further weight to the existence of hybrid vigor
in domestic dogs. Although the difference in effect shown might not
appear to be substantial, it is likely that many of the crossbreds in our
study were not first-generation crosses and therefore would have lost
much of the additional health gains shown by first-generation
crosses.32 It is possible that any true reduction in seizure prevalence
in crossbreds may have been much higher specifically in the first-
generation subset of crosses but it was not possible to identify these
dogs in the current study. The heterogeneity in genetics and health
among the many individual breeds that exist among the purebred
grouping should act as a further caveat to facile acceptance of the
hybrid vigor concept.28 Relative changes in the proportions of some
common breeds that are either predisposed or protected to certain
diseases could dramatically affect the overall probability of disease in
purebred dogs overall. From this it is clear that resolving the hybrid
vigor question in dogs has quite some way to go.
Exploration of associations, in both predisposition and protective
directions, between individual breeds and the occurrence of seizures
was of particular interest in this study. After accounting for other rele-
vant factors, the final multivariable identified predisposition to sei-
zures in 11 breeds with odds ratios ranging up to 3.41 times higher
than that of Labrador Retrievers. Although the Labrador Retriever
itself has previously been reported as a predisposed breed for epilepsy
with a reported lifetime prevalence of 3.1%,39 the current study
elected to use the Labrador Retriever instead of crossbreds as the
comparator breed in contrast to other previous studies9. Crossbred
dogs, by definition, provide highly uncertain genetic structure, body
FIGURE 1 A: Seizure cases per year (n = 3,704) in the UK dog population under primary veterinary care B: Seizure non-cases per year (n =
445,674) in the UK dog population under primary veterinary care
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Breeds Labrador Retriever Base < 0.001
Pug 3.41 2.71-4.28 < 0.001
Basset Hound 2.13 1.38-3.30 0.001
Dogue de Bordeaux 2.10 1.37-3.22 0.001
Boxer 1.95 1.57-2.42 < 0.001
Beagle 1.91 1.40-2.59 < 0.001
French Bulldog 1.87 1.17-2.98 0.009
British Bulldog 1.84 1.31-2.58 < 0.001
Border Terrier 1.79 1.42-2.27 < 0.001
Pomeranian 1.57 1.01-2.43 0.043
Chihuahua 1.50 1.20-1.89 < 0.001
Border Collie 1.41 1.17-1.69 < 0.001
King Charles Spaniel 1.39 0.89-2.17 0.15
Patterdale Terrier 1.26 0.84-1.88 0.27
Cavalier King Charles Spaniel 1.22 0.98-1.52 0.070
Yorkshire Terrier 1.14 0.95-1.37 0.16
Labradoodle 1.13 0.74-1.74 0.56
Weimaraner 1.13 0.70-1.82 0.62
Akita 1.11 0.68-1.81 0.68
Toy Poodle 1.06 0.66-1.72 0.80
Husky 1.05 0.71-1.55 0.81
German Shepherd Dog 1.02 0.82-1.26 0.88
Designer 1.00 0.70-1.44 0.99
Miniature Schnauzer 0.97 0.67-1.40 0.854
Miniature Dachshund 0.83 0.53-1.31 0.435
Golden Retriever 0.83 0.62-1.11 0.215
Staffordshire Bull Terrier 0.81 0.68-0.96 0.016
Jack Russell Terrier 0.79 0.66-0.94 0.007
Crossbred 0.75 0.66-0.86 < 0.001
Bichon 0.69 0.49-0.97 0.034
Lurcher 0.68 0.44-1.05 0.083
Springer Spaniel 0.66 0.47-0.94 0.022
Lhasa Apso 0.65 0.46-0.91 0.011
Rottweiler 0.54 0.36-0.82 0.004
Shih-tzu 0.53 0.40-0.70 < 0.001
West Highland White Terrier 0.52 0.40-0.67 < 0.001
English Springer Spaniel 0.50 0.34-0.74 < 0.001
Cocker Spaniel 0.44 0.34-0.58 < 0.001
Unrecorded 0.72 0.38-1.37 0.31
Other purebreds and designers
breed types
0.89 0.77-1.03 0.11
Age (years) 0.00 - ≤ 0.50 0.30 0.20-0.45 < 0.001 < 0.001
0.50 - ≤ 3.00 Base < 0.001
3.00 - ≤ 6.00 2.13 1.90-2.39 < 0.001
6.00 - ≤ 9.00 2.89 2.57-3.25 < 0.001
9.00 - ≤ 12.00 3.63 3.21-4.11 < 0.001
≥ 12.00 6.63 5.88-7.47 < 0.001
Unrecorded 1.46 0.98-2.18 0.065
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conformation and parental-breed contribution compared with their
purebred counterparts that are more standardized with higher genetic
homozygosity, breed standards for conformation and defined parent-
age 40 The high count of Labrador Retrievers in the study also enabled
high statistical power to explore breed risks.41 However, interested
readers who still wish to evaluate breed predisposition using cross-
breds as the comparator category can still check for overlap of the
95% CI for each category; categories that do not overlap can be inter-
preted as showing statistically significant differences in their odds of
diagnosis as seizure cases. The 11 breeds with significantly higher
odds ratios compared to the Labrador Retriever were the Pug, Basset
Hound, Dogue de Bordeaux, Boxer, Beagle, French Bulldog, British
Bulldog, Border Terrier, Pomeranian, Chihuahua and Border Collie.
The majority of previous studies in this area have focused on epi-
lepsy in dog breeds and often went even further by specifically target-
ing the epilepsy subset with a suspected inheritance of idiopathic
epilepsy.10 Many of these earlier studies relied on relatively small
groups of dogs or families that made it problematic to generalize the
findings to the overall breed although recently some larger studies
have reported breed-specific epilepsy prevalence estimates.10
There are differing etiologies for epileptic seizures for Pugs (nec-
rotizing encephalopathy) 42 and the Basset Hounds (Lafora disease).43
Seizure activity in the Dogue de Bordeaux is associated with a genetic
predisposition but based on a small sample size of 5 dogs.44 Seizures
and their etiology have also been investigated for 3 of the other pre-








relative to breed and sex mean
Lower Base < 0.001 < 0.001
Equal/Higher 1.06 0.99-1.14 0.082
Unrecorded 0.76 0.69-0.84 < 0.001
Sex-neuter Female/Entire Base < 0.001 < 0.001
Female/Neutered 1.14 1.01-1.28 0.039
Female/ Unrecorded 1.43 1.24-1.65 < 0.001
Male/Entire 1.47 1.30-1.66 < 0.001
Male/Neutered 1.34 1.19-1.51 < 0.001
Male/ Unrecorded 1.73 1.51-1.99 < 0.001
Not recorded/ Unrecorded 1.00 0.49-2.05 0.99
Multivariable logistic regression model for risk factors associated with seizures in dogs under primary-care in the UK; aCI confidence interval.
TABLE 4 Multivariable logistic regression results for variables that replaced breed
Variable Category Odds ratio 95%CIa p-value Variable P-value
Purebred Crossbred Base < 0.001
Purebred 1.28 1.18-1.39 < 0.001
Designer 1.18 0.93-1.50 0.16






Gundog 1.05 0.95-1.16 0.34
Hound 1.20 1.01-1.44 0.042
Pastoral 1.42 1.25-1.60 < 0.001
Terrier 1.03 0.92-1.15 0.59
Toy 1.68 1.52-1.86 < 0.001
Utility 1.09 0.96-1.24 0.16
Working 1.49 1.28-1.72 < 0.001
Adult (>18months)
bodyweight (kg)
< 10.00 Base < 0.001
10.00 - ≤ 20.00 0.92 0.84-1.01 0.092
20.00 - ≤ 30.00 0.92 0.83-1.02 0.110
30.00 - ≤ 40.00 1.11 1.00-1.24 0.061
≥ 40.00 1.24 1.08-1.41 0.002
Unrecorded 0.74 0.66-0.83 < 0.001
Results for variables that replaced the breed variable in the final breed multivariable logistic regression model (with age category, bodyweight relative to
breed mean sex and neuter status) to evaluate risk factors associated with seizures in dogs under primary veterinary care in the UK. Bodyweight relative to
breed mean was also removed for adult bodyweight, aCI confidence interval.
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Border Terrier,9,46 Labrador Retriever,39 and the Chihuahua.47 How-
ever, there are no reliable reports on seizure activity in the French
Bulldog, British Bulldog and Pomeranian. The findings of the current
study go further than many of these previous studies and additionally
include dogs with seizures that are both reactive as well as epileptic in
order to give a more holistic view of the seizure predispositions that
includes both genetic and environmental proclivities.
A protective effect for seizures was identified in Shih-tzu, West
Highland White Terrier, English Springer Spaniel and Cocker Spaniel.
A previous primary-care veterinary study similarly showed reduced
risk to epilepsy of unknown origin in English Springer Spaniels and
West Highland White Terrier in the UK.9 Breed health studies to date
have heavily focused on predisposition to disease.28,48 However, evi-
dence to support protective disease effects, both between and within
breeds, is increasing needed to support planned breed health reforms
such as outcrossing to other breeds or to breed strains from other
countries.49
Increased risk for epileptic seizures in male dogs is recognized
across all dogs types 8,9,50–53 as well as within specific breeds.10 Our
analysis of UK primary-care veterinary data that included both epilep-
tic and reactive seizures also revealed a higher risk for male dogs. An
interaction effect was noted between neutering and sex whereby the
effect the neutering was not equal between the sexes. For this reason,
the final multivariable model reported the values for each combination
of sex and neuter status separately. Although neutering is a time
dependent event whereby animals have an increased opportunity to
become neutered as they age, the final multivariable model did take
age into account and still showed an increased odds of seizures in
neutered compared with entire bitches. This effect appears to be
quite sex-specific however and no significant effect of neutering on
seizure risk in males was noted. However, a word of caution in rela-
tion to the potential benefits of neutering in bitches: studies such as
the current cross-sectional analysis can only show statistical associa-
tion and must not be taken on their own as evidence of causality.31,54
It is also possible that these associations stem from reverse causality
effects whereby bitches that show seizures might be more likely to be
removed from the breeding pool and then neutered rather than the
other way around.52,55 Future cohort analyses that follow animals
over time to collect date information on the seizure onset and neuter-
ing as well as the rationale for the neutering decision are required to
clarify the true role of neutering and seizure occurrence.
In agreement with previous studies, the current study identified
increasing seizure risk with aging.39,52 It is also worth noting that our
study design reported the age of all cases during 2013 rather than
reporting the age that these animal first became a case. This means
that the inference from the results describes the probability for sei-
zure cases existing within these age groups (prevalence) rather than
the probability of new cases developing during these ages (incidence).
However, a detailed investigation of seizure etiologies within the age
groups was beyond the scope the study and would be required to fur-
ther explore differing seizure etiologies across the age groups. A study
of dogs referred for examination in Austria showed that idiopathic
epilepsy was 3.25 times more likely to be the cause for seizure onset
in dogs aged one to five years compared to structural epilepsy 56
whereas a US study of referred dogs identified that 65% of seizure
cases older than five years were associated with structural epilepsy.57
Dogs weighing over 40.00 kg in absolute bodyweight had signifi-
cantly higher odds and dogs weighing between 30.00 - ≤ 40.00 kg
had a tendency to higher odds for seizures compared with dogs
weighing under 10.00 kg. Although these findings might suggest
increased seizure risk in larger dogs, it is also possible that these asso-
ciations with bodyweight might result from seizure disease manage-
ment using anti-convulsive treatment. Bodyweight gain due to
polyphagia has been described as a common adverse effect of many
antiepileptic drugs.58 It is also worth noting that no effect was identi-
fied within breeds between dogs that weighed over or under their
breed and sex average bodyweight.
In common with other epidemiological studies using primary-care
veterinary clinical data, this study had some limitations.16,59 Retro-
spective identification of cases with seizures relied on the diagnostic
acumen and reporting of the veterinarians contributing data to the
VetCompass™ Program. Information about seizure occurrence is
often based on description by owners and the veterinarian might not
often witness the actual seizure event directly, and therefore some
seizures that occur when dogs are not under observation by the
owner might be missed or conversely falsely classified as seizure. In
addition, less severe, non-generalized seizures might not even be rec-
ognized as seizures by the owner and therefore might not be reported
to the veterinarian. Even in human patients with epilepsy, up to 38%
of focal seizures go unrecognized 60–62 and similar under-reporting of
seizures has been considered in dogs.63 Thus, the results of the pre-
sent study might underestimate the true absolute period prevalence
of seizures in the UK canine population but these effects are unlikely
to affect the results of the risk factor analyses where similar under-
reporting is expected across all categories within each variable.64
In conclusion, this analysis of over 450,000 dogs under primary
veterinary care shows that the combined effects of epileptic and reac-
tive seizures are a relatively common clinical finding with 0.82% of UK
dogs affected in a 1-year period. As seizure diagnosis and manage-
ment therefore constitute an important role in clinical practice, these
results highlighting particular breeds, sex and aging as significant risk
factors should assist veterinarian practitioners to identify and alert
owners to dogs at higher risk. Enhanced owner awareness could pro-
mote earlier, faster and more reliable diagnosis and treatment to sup-
port improved animal welfare. These results can also assist
pharmacovigilance efforts by providing baseline data from the overall
population to optimize interpretability of seizures when reported as
suspected adverse reaction to medication use.
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